Elekta AB (publ) (OTCMKTS:EKTAY) Sets New 12-Month Low – Should You Sell?

Elekta AB (publ) (OTCMKTS:EKTAY) shares reached a new 52-week low during trading on Wednesday . The company traded as low as $5.57 and last traded at $5.58, with a volume of 19699 shares changing hands. The stock had previously closed at $5.72.

Elekta AB (publ) Trading Down 2.4 %

The business has a 50 day moving average of $6.41 and a 200 day moving average of $6.58. The company has a quick ratio of 0.74, a current ratio of 0.99 and a debt-to-equity ratio of 0.45. The firm has a market cap of $2.14 billion, a price-to-earnings ratio of 20.41 and a beta of 1.23.

Elekta AB (publ) (OTCMKTS:EKTAY) last issued its quarterly earnings results on Wednesday, August 28th. The company reported $0.04 earnings per share (EPS) for the quarter. Elekta AB (publ) had a return on equity of 12.23% and a net margin of 6.25%. The firm had revenue of $359.76 million for the quarter. On average, research analysts forecast that Elekta AB will post 0.41 earnings per share for the current fiscal year.

Elekta AB (publ) Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.